Table 1.
hERG channel activation (V½ and slope factor) values in HEK-293 cell and neonatal mouse cardiomyocyte expression systems
| WT hERG |
N470D hERG |
G601S hERG |
ΔY475 hERG |
|||||
|---|---|---|---|---|---|---|---|---|
| V½, mV | k, mV/e-fold change | V½, mV | k, mV/e-fold change | V½, mV | k, mV/e-fold change | V½, mV | k, mV/e-fold change | |
| Neonatal mouse cardiomyocytes | −14.6 ± 3.0 | 5.9 ± 0.3 | −43.6 ± 2.6 | 6.3 ± 0.6 | −14.4 ± 2.1 | 5.3 ± 0.5 | −25.9 ± 2.1 | 6.0 ± 0.1 |
| HEK-293 cells | −11.3 ± 0.3 | 6.9 ± 0.2 | −40.4 ± 1.2 | 6.7 ± 0.4* | −16.5 ± 6.4 | 6.9† | −30 ± 0.3 | 6.1 ± 0.2 |
Values are means ± SE. V½, voltage at which peak tail current is half-maximal; k, slope factor; WT, wild type. G601S and N470D tail currents were recorded after pharmacological correction by E4031 followed by drug washout. Data for N470D and G601S hERG in human embryonic kidney (HEK)-293 cells are from published literature (*Ref. 45 and †Ref. 31).